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Introduction
Familial Mediterranean Fever (FMF) is the most com-
mon recurrent autoinflammatory fever syndrome. The
diagnosis is based on clinical findings and supported by
genetic analysis. Recently new set of diagnostic criteria
were established for the diagnosis of familial Mediterra-
nean fever (FMF) in childhood by Yalcinkaya et al.
Objectives
The aim of this study was to validate these new criteria
set among FMF patients and to compare it by Tel
Hashomer criteria.
Methods
Patient group was composed of 135 FMF patients. 165
patients who were admitted to our outpatient clinic with
FMF like symptoms were reviewed as a control group.
Demographic findings and laboratory examination of
both groups were reviewed retrospectively. According to
the new criteria, the diagnosis of FMF was established by
the presence of two or more of five criteria (fever,
abdominal pain, chest pain, arthritis, family history of
FMF). Patients were evaluated by the new criteria set and
also by the Tel Hashomer criteria and both criteria were
compared in the terms of sensitivity and specificity.
Results
Mean age of the patients was 14.02 ± 5.32 years (min-
max: 1,1-18). Mean age of the symptoms was 6.98 ±
4.65 (min-max: 0.6-17) years. Mean age of diagnosis was
detected as 8.76 ± 4.58 years (min-max:1.1-18). The
mean time of diagnostic delay was detected as 1.8 years.
New sets of pediatric diagnostic criteria were found to
be as specific and as sensitive as Tel Hashomer criteria.
The 5 new criteria that was used by Yalcinkaya was
found in patient with FMF in a significantly higher man-
ner than the controls (p < 0.05). The presence of at least
2 criteria of Yalcinkaya’s criteria was seen to be ade-
quate to diagnose FMF. When we evaluated the relation
between genetic features and new pediatric criteria we
found that the specificity and sensitivity of these criteria
was similar for patients with heterozygous mutations,
compound heterozygous and patients with no mutation
as well as homozygous patients.
Conclusion
This study has suggested that sensitivity and specificity
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